Physician profile
Mazda Biria
NPI 1194847244
$10,023.30
in general payments reported to CMS, 2019-2025
31 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,432 · 2020: $342 · 2021: $1,194 · 2022: $1,379 · 2023: $1,386 · 2024: $2,058 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788 · Travel and Lodging: $1,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,788.20 |
| Travel and Lodging | $1,889.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,274.12 | 2019-2025 | Aveir, Amplatzer Amulet, Mitraclip |
| Biosense Webster, INC. | $1,735.12 | 2019-2025 | Carto 3, N/A, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $762.25 | 2019 | |
| Boston Scientific Corporation | $685.91 | 2019-2025 | Watchman Flx |
| Biotronik INC. | $476.43 | 2020-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Janssen Pharmaceuticals, INC | $470.71 | 2019-2023 | Xarelto |
| Medtronic, INC. | $416.79 | 2021-2025 | Corevalve Evolut R, Micra, Aurora Ev-Icd Mri Surescan |
| Pfizer INC. | $277.41 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $276.79 | 2019-2024 | |
| Novo Nordisk INC | $258.03 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $189.85 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $185.08 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.05 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $144.12 | 2020-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $126.44 | 2021-2023 | Verquvo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.90 | 2019-2021 | |
| Cardiva Medical, INC. | $72.67 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Amarin Pharma, INC. | $65.84 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $49.04 | 2020-2023 | Definity |
| Itamar Medical INC | $38.98 | 2021 | |
| Philips North America LLC | $38.76 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.52 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $33.71 | 2021-2022 | |
| Atricure, INC. | $21.37 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.37 | 2022 | |
| Irhythm Technologies, INC. | $18.73 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $17.38 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $17.36 | 2022 | |
| Baxter Healthcare | $17.35 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Astellas Pharma US INC | $15.79 | 2023 | Lexiscan |
| Cvrx, INC. | $11.43 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mazda Biria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.